CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in infertility rates
3.4.1.2. Delayed pregnancies among women
3.4.1.3. Technological advancements in IVF devices
3.4.2. Restraints
3.4.2.1. High cost of IVF treatment
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.3.2. Rise in number of fertility clinics
3.4.3.3. Rise in trend of fertility tourism
CHAPTER 4: IVF DEVICES AND CONSUMABLES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Instruments
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Instruments IVF Devices and Consumables Market by Type
4.3. Accessories and Disposables
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Reagents and Media
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Reagents and Media IVF Devices and Consumables Market by Type
CHAPTER 5: IVF DEVICES AND CONSUMABLES MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Fresh Embryo IVF
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Frozen Embryo IVF
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Donor Egg IVF
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: IVF DEVICES AND CONSUMABLES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Fertility Clinics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Hospitals
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Surgical Centers
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Clinical Research Institutes
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: IVF DEVICES AND CONSUMABLES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Technology
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Product
7.2.5.1.2. Market size and forecast, by Technology
7.2.5.1.3. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Product
7.2.5.2.2. Market size and forecast, by Technology
7.2.5.2.3. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Product
7.2.5.3.2. Market size and forecast, by Technology
7.2.5.3.3. Market size and forecast, by End User
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Technology
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Product
7.3.5.1.2. Market size and forecast, by Technology
7.3.5.1.3. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Product
7.3.5.2.2. Market size and forecast, by Technology
7.3.5.2.3. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Product
7.3.5.3.2. Market size and forecast, by Technology
7.3.5.3.3. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Product
7.3.5.4.2. Market size and forecast, by Technology
7.3.5.4.3. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Product
7.3.5.5.2. Market size and forecast, by Technology
7.3.5.5.3. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Product
7.3.5.6.2. Market size and forecast, by Technology
7.3.5.6.3. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Technology
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Product
7.4.5.1.2. Market size and forecast, by Technology
7.4.5.1.3. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Product
7.4.5.2.2. Market size and forecast, by Technology
7.4.5.2.3. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Product
7.4.5.3.2. Market size and forecast, by Technology
7.4.5.3.3. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Product
7.4.5.4.2. Market size and forecast, by Technology
7.4.5.4.3. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Product
7.4.5.5.2. Market size and forecast, by Technology
7.4.5.5.3. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Product
7.4.5.6.2. Market size and forecast, by Technology
7.4.5.6.3. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Technology
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Product
7.5.5.1.2. Market size and forecast, by Technology
7.5.5.1.3. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Product
7.5.5.2.2. Market size and forecast, by Technology
7.5.5.2.3. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Product
7.5.5.3.2. Market size and forecast, by Technology
7.5.5.3.3. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Product
7.5.5.4.2. Market size and forecast, by Technology
7.5.5.4.3. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Cook Group
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Key strategic moves and developments
9.2. Cooper Companies, Inc.
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Genea Limited
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Key strategic moves and developments
9.4. Fujifilm Holdings Corporation
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.4.7. Key strategic moves and developments
9.5. Thermo Fisher Scientific, Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.5.7. Key strategic moves and developments
9.6. Vitrolife AB
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Hamilton Thorne Ltd.
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. Esco Micro Pte. Ltd.
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Key strategic moves and developments
9.9. Kitazato Corporation
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Nidacon International AB
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
| ※参考情報 体外受精（IVF）は、不妊治療の一つであり、卵子と精子を体外で受精させ、その胚を女性の子宮に戻す方法です。このプロセスは多くの専門的な機器や消耗品に依存しており、それらの適切な使用が成功率に大きな影響を与えます。 まず、体外受精に使用される機器には、インキュベーター、顕微鏡、顕微授精用のマイクロピペット、培養皿、凍結装置などがあります。インキュベーターは、胚の成長に最適な温度と湿度を保つために重要な役割を果たします。通常、37度の温度が維持され、二酸化炭素濃度も調整されて、胚の発育環境が整えられます。 顕微鏡は、卵子や精子、胚の状態を観察するために欠かせない装置です。特に、顕微授精（ICSI）の場合、高倍率の顕微鏡が必要とされ、精子を直接卵子に注入する際に重要です。マイクロピペットは、極めて細かい操作を可能にするため、特殊な設計がされており、卵子や胚を扱うための必需品です。 培養皿は、卵子や胚を培養するための基盤となる器具です。特に、胚の発育段階に応じて最適な培養液が使用され、これによって胚の質が大きく影響されます。凍結装置は、胚を長期保存するために必要であり、急速凍結技術を用いることで胚の細胞にダメージを与えずに保存することが可能です。 次に、消耗品について考えます。体外受精の過程には、卵子や胚を取り扱うための各種試薬や培養液、滅菌された器具が必要です。これらは一度きりの使用が求められ、特に感染防止のためには徹底した滅菌が重要です。たとえば、培養液には、成長因子やホルモン、栄養素が含まれており、胚の正常な発育に寄与します。 IVFでは、体外受精を支える関連技術も重要です。例えば、遺伝子検査技術が進化し、胚の遺伝子的な異常を早期に発見できるようになりました。これにより、選別された健康な胚のみを選ぶことができ、着床率や妊娠率の向上が期待されます。また、人工知能（AI）の導入も進んでおり、胚の評価や選別の際にデータ分析を活用することで、より精度の高い判断が可能になります。 さらに、体外受精のプロセスは、ホルモン治療と密接に関連しています。女性の卵巣を刺激するために使用されるホルモン注射が必要であり、そのための用具も消耗品として重要です。これらの治療が適切に行われることで、卵子の採取数や質が向上し、成功につながります。 体外受精は、医学的な進歩により、さまざまな技術や機器が登場しています。これらの技術は日々進化し続けており、新しい治療法が開発されることで、より多くの人々が妊娠の機会を得られるようになります。体外受精に関する機器や消耗品の理解は、医療従事者だけでなく、不妊治療を受ける患者にとっても重要です。適切な知識を持つことが成功率の向上に寄与するでしょう。 このように、体外受精における機器や消耗品、そしてそれに関連する技術は、成功するために欠かせない要素です。現代の医療の進歩により、より多くの不妊に苦しむカップルが希望を持てるようになっています。これからもさらなる技術革新が期待され、体外受精における成功の可能性が広がることでしょう。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
